Dr. David AuCoin is an Associate Professor in the Department of Microbiology and Immunology at the University of Nevada School of Medicine (UNSOM). His primary research focus is to develop rapid diagnostics for resource poor settings. He is also the co-founder and Chief Scientific Officer of DxDiscovery (2012), a UNR “startup” focused on translating diagnostic research into FDA approved products. Dr. AuCoin has three active research grants through the National Institutes of Health. Two additional grants were recently secured through the Department of Homeland Security (DHS) and the Naval Research Laboratory (DoD). Total combined funding for these grants is $1.1 million/year. All these projects rely on the identification of secreted or circulating microbial antigens that can be targeted for diagnosis of disease. Dr. AuCoin received a B.S. from the University of Massachusetts at Amherst (1993) followed by a M.S. (1999) and Ph.D. in Cell and Molecular Biology from the University of Nevada (2002). Dr. AuCoin completed a postdoctoral fellowship at Stanford University (2005). He lectures on medical microbiology to UNSOM medical students and recently assisted in the creation of a new undergraduate major, Molecular Microbiology and Immunology (MMI), through the College of Science at UNR.
Inexpensive diagnostic tests for resource poor countries